Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission

ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the sole curative option for myeloid malignancies, though high toxicity from conditioning regimens and complications like graft‐versus‐host disease (GVHD) limit its success. The potential benefit of incorporat...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Shuling Yu, Wanchuan Zhuang, Shengfa Gao, Tongyu Li, Xiao Yan, Guifang Ouyang, Ping Zhang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-07-01
Serie:	Cancer Medicine
Soggetti:	allogenic hematopoietic stem cell transplantation AML decitabine graft‐versus‐host disease MDS
Accesso online:	https://doi.org/10.1002/cam4.71081
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!